Cite
Safety of SGLT2 Inhibitors: A Pharmacovigilance Study from 2013 to 2021 Based on FAERS
MLA
Xiang Zhou, et al. “Safety of SGLT2 Inhibitors: A Pharmacovigilance Study from 2013 to 2021 Based on FAERS.” Frontiers in Pharmacology, vol. 12, Dec. 2021. EBSCOhost, https://doi.org/10.3389/fphar.2021.766125.
APA
Xiang Zhou, Xiaofei Ye, Xiaojing Guo, Dongxu Liu, Jinfang Xu, Fangyuan Hu, Yinghong Zhai, Yongqing Gao, Xiao Xu, Ziwei Dong, & Jia He. (2021). Safety of SGLT2 Inhibitors: A Pharmacovigilance Study from 2013 to 2021 Based on FAERS. Frontiers in Pharmacology, 12. https://doi.org/10.3389/fphar.2021.766125
Chicago
Xiang Zhou, Xiaofei Ye, Xiaojing Guo, Dongxu Liu, Jinfang Xu, Fangyuan Hu, Yinghong Zhai, et al. 2021. “Safety of SGLT2 Inhibitors: A Pharmacovigilance Study from 2013 to 2021 Based on FAERS.” Frontiers in Pharmacology 12 (December). doi:10.3389/fphar.2021.766125.